Insmed Incorporated to Discuss Litigation Settlement with Tercica, Inc.

March 7, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

RICHMOND, Va.--(BUSINESS WIRE)--Insmed (NASDAQ:INSM) announced that it will host a conference call on Wednesday, March 7 at 11:00 a.m. (ET) to discuss the litigation settlement with Genentech and Tercica, and other business details.

Twitter
LinkedIn
Facebook
Email
Print

Events Legal

Insmed Incorporated